Perspective and desire in comparative effectiveness research: The relative unimportance of mere preferences, the central importance of context

PharmacoEconomics

Volumn 28, Issue 10, 2010, Pages 889-897

  Culyer, Anthony J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cost effectiveness; Decision making; Formularies; Health policy; Treatment outcome

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG INDUSTRY; HEALTH CARE FINANCING; HEALTH CARE POLICY; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW;

COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; DECISION MAKING; ECONOMICS, PHARMACEUTICAL; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 77956502145     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11535270-000000000-00000     Document Type: Review

References (35)

1. Keynes JM. Essays in persuasion. London: Macmillan, 1931: 373
2. Drummond MF, Sculpher MJ, Torrance GW, et al. Meth-ods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005
3. Gold MR, Siegel JE, Russell LB, et al. editors. Cost-effec-tiveness in health and medicine. New York: Oxford University Press, 1996
4. Arrow KJ. Uncertainty and the welfare economics of medi-cal care. Am Econ Rev 1963; 53: 941-973
5. Brouwer WBF, Culyer AJ, Job N, et al. Welfarism vs extra-welfarism. J Health Econ 2008; 27: 325-338
6. Pigou AC. The economics of welfare. 4th ed. London: Macmillan, 1932
7. Olsen JA, Donaldson C. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Soc Sci Med 1998; 46: 1-12
8. Ryan M, Scott DA, Reeves C, et al. Eliciting public pre-ferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5: 1-186
9. Claxton K, Sculpher MJ, Culyer AJ. Mark versus Luke? Appropriate methods for the evaluation of public health interventions [CHE research paper no. 31]. York: Centre for Health Economics, University of York, 2007
10. Culyer AJ, Williams AH, Lavers RJ. Social indicators: health. Soc Trends 1971; 2: 31-42
11. Coast J, Smith RD, Lorgelly P. Welfarism, extra-welfarism and capability: the spread of ideas in health economics. Soc Sci Med 2008; 67: 1190-1198
12. Culyer AJ. Commodities, characteristics of commodities, characteristics of people, utilities and the quality of life. In: Baldwin S, Godfrey C, Propper C, editors. The quality of life: perspectives and policies. London: Routledge, 1990: 9-27
13. Sinclair JC, Torrance GW, Boyle MH, et al. Evaluation of neonatal intensive care programs. N Engl J Med 1981; 305: 489-494
14. Torrance GW, Thomas WH, Sackett DL. A utility max-imization model for evaluation of health care programs. Health Serv Res 1972; 7: 118-133
15. Kaplan RM, Bush JW. Health related quality of life mea-surement for evaluation research and policy analysis. Health Psychol 1982; 1: 61-80
16. Sugden R, Williams AH. The principles of practical cost-benefit analysis. Oxford: Oxford University Press, 1982
17. Rawls J. A theory of justice. Cambridge (MA): The Belknap Press of Harvard University Press, 1971
18. Musgrave R. The theory of public finance. 3rd ed. New York: McGraw-Hill, 1959
19. Culyer AJ. Merit goods and the welfare economics of coercion. Public Financ 1971; 26: 546-572
20. Harris J. Maximising the health of the whole community: the case against. In: New B, editor. Rationing: talk and action. London: King's Fund and BMJ, 1997: 100-106
21. Culyer AJ. Maximising the health of the whole community: the case for. In: New B, edtor. Rationing: talk and action. London: King's Fund and BMJ, 1997: 95-100, 106-107
22. Mookherjee D. Decentralisation, hierarchies and incentives: a mechanism design perspective. J Econ Lit 2006; 44: 367-390
23. Paulden P, Claxton K. Budget allocation and the revealed social rate of time preference for health [Centre for Health Economics research paper 053]. York: University of York, 2009
24. Culyer AJ, McCabe C, Briggs AH, et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy 2007; 12: 56-58
25. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2004
26. Weinstein MC, Stason WB. Foundationsofcost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-721
27. Keeler EB, Cretin S. Discounting of life-saving and other non-monetary effects. Manage Sci 1983; 29: 300-306
28. Lipscomb J, Weinstein MC, Torrance GW. Time preference. In: Gold MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996: 214-246
29. Claxton K, Sculpher M, Culyer A, et al. Discounting and cost-effectiveness in NICE: stepping back to sort out a confusion. Health Econ 2006; 15 (1): 1-4
30. Parsonage M, Neuburger H. Discounting and health bene-fits. Health Econ 1992; 1: 71-76
31. Gravelle H, Smith D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Econ 2001; 10: 587-599
32. Van Hout BA. Discounting costs and effects: a recon-sideration. Health Econ 1998; 7: 581-594
33. Brouwer WBF, Niessen LW, Postma MJ, et al. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ 2005; 331: 446-448
34. Claxton K, Paulden M, Gravelle H, et al. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. Epub 2010 May 12
35. Lavis J. Research, public policymaking, and knowledge-translation processes: Canadian efforts to build bridges. J Contin Educ Health Prof 2006; 26: 37-45